- Home
- RLAY vs MNTSW Comparison
RLAY vs MNTSW Comparison
Compare RLAY & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- MNTSW
- Stock Information
- Founded
- RLAY 2015
- MNTSW N/A
- Country
- RLAY United States
- MNTSW United States
- Employees
- RLAY N/A
- MNTSW 123
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- MNTSW Military/Government/Technical
- Sector
- RLAY Health Care
- MNTSW Industrials
- Exchange
- RLAY Nasdaq
- MNTSW Nasdaq
- Market Cap
- RLAY 576.1M
- MNTSW N/A
- IPO Year
- RLAY 2020
- MNTSW 2019
- Fundamental
- Price
- RLAY $3.60
- MNTSW $0.03
- Analyst Decision
- RLAY Strong Buy
- MNTSW
- Analyst Count
- RLAY 11
- MNTSW 0
- Target Price
- RLAY $18.40
- MNTSW N/A
- AVG Volume (30 Days)
- RLAY 1.5M
- MNTSW N/A
- Earning Date
- RLAY 08-05-2025
- MNTSW N/A
- Dividend Yield
- RLAY N/A
- MNTSW N/A
- EPS Growth
- RLAY N/A
- MNTSW N/A
- EPS
- RLAY N/A
- MNTSW N/A
- Revenue
- RLAY $7,679,000.00
- MNTSW N/A
- Revenue This Year
- RLAY $17.59
- MNTSW N/A
- Revenue Next Year
- RLAY N/A
- MNTSW N/A
- P/E Ratio
- RLAY N/A
- MNTSW N/A
- Revenue Growth
- RLAY N/A
- MNTSW N/A
- 52 Week Low
- RLAY $1.78
- MNTSW N/A
- 52 Week High
- RLAY $10.72
- MNTSW N/A
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- MNTSW N/A
- Support Level
- RLAY $3.50
- MNTSW N/A
- Resistance Level
- RLAY $3.86
- MNTSW N/A
- Average True Range (ATR)
- RLAY 0.18
- MNTSW 0.00
- MACD
- RLAY 0.02
- MNTSW 0.00
- Stochastic Oscillator
- RLAY 65.79
- MNTSW 0.00
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About MNTSW Momentus Inc. Warrant
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.